Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Michael Wechsler, MD
National Jewish Health, 1400 Jackson St Denver, CO 80206
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Brussels, Belgium
- Research Site
Brussels, Belgium
- Research Site
Calgary, Alberta, Canada
- Research Site
Hamilton, Ontario, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Toronto, Ontario, Canada
- Research Site
Dijon, France
- Research Site
Marseille, France
- Research Site
Montpellier, France
- Research Site
Nantes, France
- Research Site
Paris, France
- Research Site
Paris, France
- Research Site
Suresnes, France
- Research Site
Toulouse, France
- Research Site
Bamberg, Germany
- Research Site
Freiburg im Breisgau, Germany
- Research Site
Hamburg, Germany
- Research Site
Kirchheim, Germany
- Research Site
Lübeck, Germany
- Research Site
Ashkelon, Israel
- Research Site
Beersheba, Israel
- Research Site
Jerusalem, Israel
- Research Site
Ramat Gan, Israel
- Research Site
Rehovot, Israel
- Research Site
Tel Aviv, Israel
- Research Site
Cuneo, Italy
- Research Site
Florence, Italy
- Research Site
Milan, Italy
- Research Site
Milan, Italy
- Research Site
Naples, Italy
- Research Site
Roma, Italy
- Research Site
Torino, Italy
- Research Site
Chiba, Japan
- Research Site
Kita-gun, Japan
- Research Site
Sagamihara-shi, Japan
- Research Site
Sendai, Japan
- Research Site
Shinjuku-ku, Japan
- Research Site
Cambridge, United Kingdom
- Research Site
Leicester, United Kingdom
- Research Site
London, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Oct 2019
- Primary completion
- 10 Aug 2023
- Completion
- 30 Nov 2026
- Last update posted
- 11 May 2026
- Registered enrollment
- 140
- Registry id
- NCT04157348
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.